Precision guidelines for soft tissue and visceral sarcomas: the evidence, expert experience and ensuring optimal care for rare cancers, a 2021 update from ESMO–EURACAN–GENTURIS

This publication has 12 references indexed in Scilit:

• Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
  Cancers, 2021
• Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma
  Current Treatment Options in Oncology, 2020
• Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
  European Journal of Human Genetics, 2020
• Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate
  Annals of Surgical Oncology, 2019
• Translating genomic risk into an early detection strategy for sarcoma
  Genes, Chromosomes and Cancer, 2018
• Treatment at low‐volume hospitals is associated with reduced short‐term and long‐term outcomes for patients with retroperitoneal sarcoma
  Cancer, 2018
• Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2018
• High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
  European Journal of Cancer, 2018
• Improved survival using specialized multidisciplinary board in sarcoma patients
  Annals of Oncology, 2017
• Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
  Annals of Surgical Oncology, 2016